In chronic obstructive pulmonary disease, a combination of ipratropium and albuterol is more effective than either agent alone. An 85-day multicenter trial. COMBIVENT Inhalation Aerosol Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples